Literature DB >> 28242049

High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Scott M Gordon1, Alan T Remaley2.   

Abstract

High density lipoproteins (HDL) represent a compositionally diverse population of particles in the circulation, containing a wide variety of lipids and proteins. Gene ontology functional analysis of the 96 commonly identified HDL binding proteins reveals that almost half of these proteins are either proteases or have known roles in protease regulation. Here, we discuss the activities of some of these proteins in regard to their roles in regulating proteases involved in inflammation, coagulation, and complement activation, particularly in the context of atherosclerosis. The overall goal of this review is to discuss potential functional roles of HDL in protease regulatory pathways based on current literature and known functions of HDL binding proteins and to promote the consideration of HDL as a global modulator of proteolytic equilibrium. Published by Elsevier B.V.

Entities:  

Keywords:  Coagulation; Complement system; High density lipoprotein; Inflammation; Protease; Protease inhibitor; SERPIN

Mesh:

Substances:

Year:  2016        PMID: 28242049      PMCID: PMC5391047          DOI: 10.1016/j.atherosclerosis.2016.11.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  109 in total

1.  Targeting proteases in atherosclerosis: hitting the nail with the hammer.

Authors:  Daniel I Simon; Mukesh K Jain
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

2.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

3.  Complement C5b-9 increases plasminogen binding and activation on human endothelial cells.

Authors:  V J Christiansen; P J Sims; K K Hamilton
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-01       Impact factor: 8.311

4.  beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.

Authors:  T Mori; H Takeya; J Nishioka; E C Gabazza; K Suzuki
Journal:  Thromb Haemost       Date:  1996-01       Impact factor: 5.249

5.  Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.

Authors:  Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan P Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

6.  The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells.

Authors:  K K Hamilton; P J Sims
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells.

Authors:  Lucia Rohrer; Clara Cavelier; Séverine Fuchs; Marc Alexander Schlüter; Wolfgang Völker; Arnold von Eckardstein
Journal:  Biochim Biophys Acta       Date:  2006-02-20

8.  Alpha 1-antitrypsin in acute myocardial infarction.

Authors:  H Gilutz; Y Siegel; E Paran; N Cristal; M R Quastel
Journal:  Br Heart J       Date:  1983-01

Review 9.  Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

Authors:  Anetta Undas; Robert A S Ariëns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-11       Impact factor: 8.311

10.  Neutrophil elastase promotes interleukin-1β secretion from human coronary endothelium.

Authors:  Mabruka Alfaidi; Heather Wilson; Marc Daigneault; Amanda Burnett; Victoria Ridger; Janet Chamberlain; Sheila Francis
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

View more
  20 in total

1.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

2.  Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr-/- mice.

Authors:  Zhi-Hong Yang; Scott M Gordon; Denis Sviridov; Shuibang Wang; Robert L Danner; Milton Pryor; Boris Vaisman; Yuka Shichijo; Nobushige Doisaki; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-04-25       Impact factor: 5.162

3.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

4.  ABCA1, ABCG1, and Cholesterol Homeostasis.

Authors:  Xiao-Hua Yu; Chao-Ke Tang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.

Authors:  W Sean Davidson; Amy S Shah; Hannah Sexmith; Scott M Gordon
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-11-18       Impact factor: 4.698

6.  Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.

Authors:  Lita A Freeman; Stephen J Demosky; Monika Konaklieva; Rostislav Kuskovsky; Angel Aponte; Alice F Ossoli; Scott M Gordon; Ross F Koby; Kelly A Manthei; Min Shen; Boris L Vaisman; Robert D Shamburek; Ajit Jadhav; Laura Calabresi; Marjan Gucek; John J G Tesmer; Rodney L Levine; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2017-06-02       Impact factor: 4.030

Review 7.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

8.  Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach.

Authors:  Miji Shin; Sora Mun; Sang Hyun Park; Jiyeong Lee; Hee-Gyoo Kang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke.

Authors:  Deanna L Plubell; Alex M Fenton; Sara Rosario; Paige Bergstrom; Phillip A Wilmarth; Wayne M Clark; Neil A Zakai; Joseph F Quinn; Jessica Minnier; Nabil J Alkayed; Sergio Fazio; Nathalie Pamir
Journal:  Circ Res       Date:  2020-08-26       Impact factor: 17.367

10.  Effect of metformin on the high-density lipoprotein proteome in youth with type 1 diabetes.

Authors:  Evgenia Gourgari; Kristen J Nadeau; Laura Pyle; Martin P Playford; Junfeng Ma; Nehal N Mehta; Alan T Remaley; Scott M Gordon
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.